Osteopenia News and Research

RSS

Osteopenia is a condition where bone mineral density is lower than normal. It is considered by many doctors to be a precursor to osteoporosis. However, not every person diagnosed with osteopenia will develop osteoporosis. More specifically, osteopenia is defined as a bone mineral density T-score between -1.0 and -2.5.

Experts warn that osteoporosis is not a healthcare priority for patients or physicians

A panel of medical experts, Congresswoman Shelley Berkley (D-NV) and Congresswoman Sue Myrick (R-NC) gathered today on Capitol Hill to examine the barriers that currently exist to proper prevention and treatment of osteoporosis, a disease that affects up to 44 million Americans.

5 May 2005

Vegetarians who don't cook their food have abnormally low bone mass

Vegetarians who don't cook their food have abnormally low bone mass, usually a sign of osteoporosis and increased fracture risk. But a research team at Washington University School of Medicine in St. Louis also found that raw food vegetarians have other biological markers indicating their bones, although light in weight, may be healthy.

28 Mar 2005

$Primary reason to diagnose and treat osteoporosis is to prevent bone fractures$

Primary reason to diagnose and treat osteoporosis is to prevent bone fractures

In an editorial in the February 28 issue of Archives of Internal Medicine, Alan L. Buchman, M.D., M.P.H., of the Feinberg School of Medicine at Northwestern University, Chicago, writes that the primary reason to diagnose and treat osteoporosis is to prevent bone fractures.

28 Feb 2005

Amgen's AMG-162 for treatment of osteoporosis will become a blockbuster by 2013

Decision Resources, Inc., forecasts that Amgen's novel biological agent for the treatment of osteoporosis, AMG-162, will become a blockbuster by 2013. Premium pricing of AMG-162 will propel the sales of this agent.

23 Feb 2005

Calcium and vitamin D treatment alone can improve bone mineral density in Crohn's patients

According to a study published today in the American Gastroenterological Association (AGA) journal Clinical Gastroenterology and Hepatology, the addition of popular bone building drugs to calcium and vitamin D therapy to treat bone loss associated with Crohn's disease is not beneficial.

1 Feb 2005

Combination therapies improve prostate cancer survival rates

The addition of six months of androgen suppression therapy (AST) to radiation therapy improves survival of patients with clinically localized prostate cancer, according to a study in the current issue of the Journal of the American Medical Association.

18 Aug 2004

$Risk for future fractures in postmenopausal women$

Risk for future fractures in postmenopausal women

Two new studies in the May 24 issue of The Archives of Internal Medicine, one of the JAMA/Archives journals, examines methods to accurately classify postmenopausal women with reduced bone mass and identify those with increased risk for future fractures.

24 May 2004